CD4 T cell respnse to Human herpesvirus-6
CD4 T 细胞对人类疱疹病毒 6 的反应
基本信息
- 批准号:9226033
- 负责人:
- 金额:$ 47.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-03-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAntiviral AgentsAutoimmune DiseasesAutoimmune thyroiditisBiochemicalBiological AssayBlood CellsBone Marrow SuppressionCD4 Positive T LymphocytesCell LineCessation of lifeCharacteristicsChildChildhoodChronicClinicalCollaborationsComplicationCytomegalovirusDataDiagnosisDiagnosticEncephalitisEpitopesExanthema SubitumFebrile ConvulsionsGoalsHospitalizationHumanHuman Herpesvirus 4Human Herpesvirus 6ImmuneImmune responseImmunocompetentImmunosuppressionInfectionInfectious AgentInterleukin-10Interleukin-2Kidney TransplantationLifeMHC Class II GenesMediatingMedicalMemoryMolecularMusNational Institute of Allergy and Infectious DiseaseNatural Killer CellsNatureNeurologicOrganOrgan TransplantationPathologyPatientsPatternPopulationPrimary InfectionProcessProteinsPulmonary InflammationReagentRegulationReportingRoleSamplingSolidStem cellsSystemT cell regulationT cell responseT memory cellT-LymphocyteT-Lymphocyte EpitopesTechniquesTestingTherapeutic immunosuppressionTransplant RecipientsTransplantationVaccinationViralVirusVirus DiseasesWorkantiviral immunitybaseclinical developmentcognitive functioncross reactivitycytokineearly childhoodexperienceexperimental studyimmunosuppressedimprovedmultiple sclerosis patientnovelpathogenperipheral bloodreactivation from latencyresponseseropositivetool
项目摘要
This project is a comprehensive look into the CD4 T cell response to human herpesvirus 6 (HHV-6), an
emergent / re-emergent human pathogen. In most people infection in childhood resolves uneventfully to a
chronic life-long infection held in check by cellular immune responses. However, viral reactivation after
immunosuppression can cause serious illness, neurological complications, and even death, and is an
important complication following organ transplantation. One aim of the project is to characterize memory T
cell responses to this chronic infection, and compare them to responses to acute infection. CD4 and CDS T
cell responses to HHV-6 will be characterized in healthy immune donors and also in kidney transplant
recipients experiencing viral reactivation. A possible role for IL-10 in regulating these responses will be
investigated. These analysis will involve ex vivo analysis of, peripheral blood and primary cell lines, using
functional assays and newly-developed class II MHC oligomers, and will be pursued in collaboration with
project 2, which is investigating analogous CD4 T cell functional subsets in mice. A second aim of the
project is to understand the role of NK cells in regulating T cell responses to HHV-6. Preliminary data
indicate that NK populations present in peripheral blood regulate CD4 T cells responding to HHV-6. Several
mechanistic hypotheses will be explored using ex vivo analysis of human peripheral blood and primary cell
lines. This work will be pursued in collaboration with project 1, which is investigating similar NK
phenomenon in other systems. A third aim of the project is to investigate and functionally characterize CD4
T cell responses to HHV-6 that are cross-reactive with other viruses. Several recently identified HHV-6 T
cell epitopes are similar to those from other common viral infections. Based on principles established in
previous work on CDS cross-reactivity patterns, we predict that the HHV-6 specific CD4 T cell response can
recognize heterologous infection by other viruses including EBV, CMV, and lAV. This prediction will be
tested using ex vivo analysis of human peripheral blood and primary cell lines, and biochemical and
structural analysis of MHC and TCR proteins. This aim will be pursued in collaboration with project 3.
该项目全面研究了CD4 T细胞对人类疱疹病毒6 (HHV-6)的反应
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lawrence J. Stern其他文献
Comparison of x-ray crystal structures of an acyl-enzyme intermediate of subtilisin Carlsberg formed in anhydrous acetonitrile and in water.
枯草杆菌蛋白酶 Carlsberg 在无水乙腈和水中形成的酰基酶中间体的 X 射线晶体结构比较。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:11.1
- 作者:
J. Schmitke;Lawrence J. Stern;A. Klibanov - 通讯作者:
A. Klibanov
Single-Particle Cryo-EM Studies of ERp44-ERAP1 and ERp44-ERAP2 Reveal their ER-Retention Mechanism
- DOI:
10.1016/j.bpj.2019.11.2767 - 发表时间:
2020-02-07 - 期刊:
- 影响因子:
- 作者:
Richa Arya;Lawrence J. Stern - 通讯作者:
Lawrence J. Stern
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen
与超抗原复合的人类 II 类组织相容性分子的三维结构
- DOI:
10.1038/368711a0 - 发表时间:
1994-04-21 - 期刊:
- 影响因子:48.500
- 作者:
Theodore S. Jardetzky;Jerry H. Brown;Joan C. Gorga;Lawrence J. Stern;Robert G. Urban;Young-in Chi;Cynthia Stauffacher;Jack L. Strominger;Don C. Wiley - 通讯作者:
Don C. Wiley
Chemical inhibition of ER aminopeptidase 1 as a tool for regulating the immunopeptidome of cancer cells
- DOI:
10.1016/j.molimm.2022.05.050 - 发表时间:
2022-10-01 - 期刊:
- 影响因子:
- 作者:
Despoina Koumantou;Eilon Barnea;Adrian Martin-Esteban;Zachary Maben;Athanasios Papakyriakou;Paraskevi Kokkala;Harris Pratsinis;Dimitris Georgiadis;Lawrence J. Stern;Arie Admon;Efstratios Stratikos - 通讯作者:
Efstratios Stratikos
Lipid Membrane Association of the T Cell Antigen Receptor ζ Subunit: Affinities and Structure
- DOI:
10.1016/j.bpj.2011.11.203 - 发表时间:
2012-01-31 - 期刊:
- 影响因子:
- 作者:
Prabhanshu Shekhar;Kerstin Zimmermann;Mathias Lösche;Lawrence J. Stern;Frank Heinrich - 通讯作者:
Frank Heinrich
Lawrence J. Stern的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lawrence J. Stern', 18)}}的其他基金
ER-aminopeptidases: Conformational regulation and antigen presentation function
ER-氨基肽酶:构象调节和抗原呈递功能
- 批准号:
10448371 - 财政年份:2020
- 资助金额:
$ 47.69万 - 项目类别:
ER-aminopeptidases: Conformational regulation and antigen presentation function
ER-氨基肽酶:构象调节和抗原呈递功能
- 批准号:
10664968 - 财政年份:2020
- 资助金额:
$ 47.69万 - 项目类别:
ER-aminopeptidases: Conformational regulation and antigen presentation function
ER-氨基肽酶:构象调节和抗原呈递功能
- 批准号:
10045425 - 财政年份:2020
- 资助金额:
$ 47.69万 - 项目类别:
HLA-DO / H2-O: modulation of MHC-II peptide diversity and Treg population control
HLA-DO / H2-O:MHC-II 肽多样性的调节和 Treg 群体控制
- 批准号:
10061538 - 财政年份:2017
- 资助金额:
$ 47.69万 - 项目类别:
HLA-DO / H2-O: modulation of MHC-II peptide diversity and Treg population control
HLA-DO / H2-O:MHC-II 肽多样性的调节和 Treg 群体控制
- 批准号:
10308470 - 财政年份:2017
- 资助金额:
$ 47.69万 - 项目类别:
New Tools for T Cell Identification and Analysis
T 细胞识别和分析的新工具
- 批准号:
7701546 - 财政年份:2009
- 资助金额:
$ 47.69万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 47.69万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 47.69万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 47.69万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 47.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 47.69万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 47.69万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 47.69万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 47.69万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 47.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 47.69万 - 项目类别:














{{item.name}}会员




